NDSU Grad Student Ranked On Forbes List

CASEY MCCARTY | THE SPECTRUM  Andrew Dalman joined Bison Microventure in spring 2012 as an undergraduate to help develop a new dental implant.
Andrew Dalman joined Bison Microventure in spring 2012 as an undergraduate to help develop a new dental implant.

From mechanical engineering to Forbes magazine, Andrew Dalman has a knack for hard work.

Forbes recognized the graduate student for his work with manufacturing and engineering industry, particularly for his work in bone technology. The magazine’s “30 Under 30” listing, showcases young entrepreneurs and leaders.

Dalman joined Bison Microventure as an undergraduate in spring 2012. The goal of his team with Bison Microventure was to develop a new type of dental implant to mount into the lower mantel of one’s jaw and to determine how well various types of implants interact with the lower mantle.

Dalman’s interest in bone technology can be derived from wanting to recreate the experience of implanting something in a human mandible.

Dalman is the CEO of Advanced Bone Technology, his start-up company. The latest work Dalman has done with Advanced Bone Technology is creating a patented composition that can be 3-D printed to create bone structure.

Originally the technology started as an expansion project off of his Bison Microventure work, Dalman and team realized that the project was bigger than they originally thought.

“This was not simply some little sub-project anymore. … The application of the technology was not exclusive in anyway to our specific application,” Dalman said.

Advanced Bone Technology’s work has a lot of practical applications too.

Presently, companies and institutions, when developing a medical device or performing types of training, testing and clinical trial, often use cadavers before testing on living people.

Cadavers are often messy, expensive, inconsistent between different cadavers and provide a multitude of administrative roadblocks that can slow down a business.

What Advanced Bone Technology’s product does is allow companies to refine their work with bones to bone technology and bypass most of the need for cadavers by working with artificial bones.

“If you can get some large percent of your bad ideas out of the way or refined into this one better idea, it really reduces the amount of late stage testing you need to do to in order to achieve the same or better result,” Dalman said.

Dalman’s work also assists cultures that are sensitive to the treatment of the dead in medical research, and also in preventing animal testing.

Looking ahead, Dalman’s company is now incorporated in the state of North Dakota. Dalman aims to bring his company’s product to the market and ultimately develop his team into a small or medium sized business.

Leave a Reply